Published on FierceBiotech (http://www.fiercebiotech.com)

SPOTLIGHT: Antisoma gets $25M milestone from Novartis

By admin

Created May 29 2008 - 5:59am

Antisoma has received a $25 million milestone payment from Novartis, triggered by the recent initiation of a phase III trial of ASA404 in non-small cell lung cancer. Release [1]

lung cancer
milestones
Novartis
Phase III

Source URL: http://www.fiercebiotech.com/story/spotlight-antisoma-gets-25m-milestone-from-novartis/2008-05-29

Links:
[1] http://www.fiercebiotech.com/press-releases/antisoma-receives-usd-25-million-milestone-payment-novartis-corporation